Skip to content

Genetic analysis of a specific DNA region (CAG repeat length) in a blood sample

Published: August 9, 2026Updated: August 16, 2026

This test measures the number of repeated CAG sequences in a gene linked to certain genetic conditions. It helps assess risk for inherited disorders.

Quick summary

["Understanding your genetic risk for conditions like Huntington’s disease or other CAG-repeat disorders."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
49015-1
Short code
SCA15 gene CAG Rpt Bld/T Ql
Synonyms
SCA15 gene CAG Rpt Bld/T Ql
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Ref low
0.8
Ref high
1.2
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
CPT
85610
SNOMED
396252006
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your doctor may recommend this test if you have a family history of genetic disorders linked to CAG repeats, such as Huntington’s disease, spinal muscular atrophy, or certain types of myotonic dystrophy. It can also be used for carrier screening or pre-symptomatic diagnosis in at-risk individuals.

What to Expect Before the Test

You’ll provide a blood sample, typically drawn from your arm. No special preparation is needed, but inform your doctor about any medications or health conditions that could affect results.

How the Test Works

The blood sample is analyzed to count the number of CAG repeats in a specific gene. This involves genetic sequencing to detect variations in the repeat length, which can differ from the general population.

What the Results Mean

Results show the exact number of CAG repeats in your DNA. Higher or lower repeat counts may indicate an increased risk for genetic disorders, but interpretation depends on clinical context and family history.

Reference range

INR: 0.8-1.2 (warfarin: 2.0-3.0)N/A

Specimen: whole-blood

Inform your healthcare provider if you are taking blood thinners. No special preparation required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test plays a critical role in genetic counseling and risk assessment for inherited conditions. It helps guide treatment plans, family planning decisions, and monitoring for early symptoms of disorders linked to CAG repeats.

Short name

CAG Repeat Testing (Blood)

Frequently asked questions

What does a high or low CAG repeat count mean?
A high or low CAG repeat count can signal an increased risk for genetic disorders, but results are not definitive without clinical evaluation. Your doctor will discuss how these findings relate to your personal health.
How long does it take to get results?
Results are typically available within 1–2 weeks after the sample is processed. Your healthcare provider will contact you with the findings.
Is this test covered by insurance?
Coverage depends on your insurance plan and clinical indication. Check with your insurer or doctor to confirm if this test is approved for your situation.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy